Recently Viewed

News Announcement

Strides Pharma Science: Announcement under Regulation 30 (LODR)-Press Release / Media Release

30-Jan-2026 Follow Value Research Online on Google download pdfDownload PDF Strides Pharma

Strides continues to deliver exceptional performance with highest ever quarterly EBITDA of Rs.2 359 million in Q3 FY26

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.